Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

HIGHLIGHTS

• who: Maciej Banach from the (UNIVERSITY) have published the paper: Personalized management of dyslipidemias in patients with diabetesu2014it is time for a new approach (2022), in the Journal: (JOURNAL)
• what: The above recommendations aim to optimize LLT in high-risk patients with diabetes (which should also refer to those with prediabetes/metabolic disturbances), where ASCVD risk is often underestimated and undertreated.
• how: Due to the concise and practical form of this guidance paper the authors have decided to mainly focus on the largest unmet need in diabetic patients-LDL-C goal achievement to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.